Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 23, 2025, 06:44
Therapeutic Plasma Exchange in Guillain-Barré Syndrome: ASFA 2023 Guidelines
Dr. Sumyea Kabir, Assistant Professor of Transfusion Medicine at BSMMU, shared a post on LinkedIn:
“Therapeutic Plasma Exchange (TPE) in Guillain-Barré Syndrome (GBS) – ASFA 2023 Snapshot
GBS is an Acute immune attack on peripheral nerves. ASFA 2023 places TPE as Category I, first-line therapy, equivalent to IVIG (but not combined).
Why it Works:
- TPE clears auto-antibodies and complement, helping nerves recover faster.
Protocol:
- ~1–1.5 plasma volumes per session
- 4–6 exchanges over 7–14 days
- Best started within the first week of symptoms.
Frontline Insight:
- I assisted in 7 GBS cases in My Residency Time at Bangladesh Medical University where, remarkably, after the first TPE session some patients regained limb movement and could sit upright. Early action truly saves function.
Monitor for Hypotension, Citrate-related Hypocalcemia, Bleeding risk, and central-line infection.
Reference: ASFA 9th Edition, 2023․”
Find more posts on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines